• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

择期经皮冠状动脉介入治疗过程中血小板反应性的围手术期变化。

Periprocedural variations of platelet reactivity during elective percutaneous coronary intervention.

机构信息

Cardiovascular Center Aalst OLV Hospital, Aalst, Belgium.

出版信息

J Thromb Haemost. 2012 Dec;10(12):2452-61. doi: 10.1111/jth.12016.

DOI:10.1111/jth.12016
PMID:23039797
Abstract

BACKGROUND

Percutaneous coronary intervention (PCI) modulates platelet reactivity (PR).

OBJECTIVES

To assess: (i) the impact of coronary interventions on periprocedural variations (Δ) of PR; (ii) whether ΔPR correlates with periprocedural myocardial infarction (PMI); and (iii) the mechanisms of these variations in vitro.

METHODS AND RESULTS

We enrolled 65 patients on aspirin (80-100 mg day(-1)) and clopidogrel (600 mg, 12 h before PCI): 15 with coronary angiography (CA group), 40 with PCI (PCI group), and 10 with rotational atherectomy plus PCI (RA group). PR was assessed by ADP, high-sensitivity ADP and thrombin receptor activator peptide 6 tests prior to, immediately after and 24 h after the procedure. E-selectin and ICAM-1 were assessed prior to and immediately after the procedure. In vitro, PR was measured during pulsatile blood flow at baseline, after balloon inflation and after stent implantation in six porcine carotid arteries and five plastic tubes. PR declined in the CA group, but significantly increased in the PCI and RA groups immediately postprocedure, and decreased to baseline at 24 h. ΔPR increased across the three groups (P < 0.0001). In the PCI group, ΔPR was directly related to total inflation time (r = 0.435, P = 0.005) and total stent length (r = 0.586, P < 0.001). The change in E-selectin significantly and inversely correlated with ΔPR (P < 0.001). No correlation was found with sICAM-1. PR increased significantly more in patients with PMI than in patients without PMI (P = 0.013). In vitro, platelet activation was observed in the presence of carotid arteries but not in the presence of plastic tubes.

CONCLUSIONS

Despite dual antiplatelet therapy, PCI affected platelet function proportionally to procedural complexity and the extent of vascular damage.

摘要

背景

经皮冠状动脉介入治疗(PCI)可调节血小板反应性(PR)。

目的

评估:(i)冠状动脉介入对围手术期 PR 变化(Δ)的影响;(ii)ΔPR 是否与围手术期心肌梗死(PMI)相关;以及(iii)这些变化的体外机制。

方法和结果

我们招募了 65 例服用阿司匹林(80-100 mg/天)和氯吡格雷(PCI 前 12 小时 600 mg)的患者:15 例接受冠状动脉造影(CA 组),40 例接受 PCI(PCI 组),10 例接受旋磨加 PCI(RA 组)。在介入治疗前、即刻和 24 小时后,通过 ADP、高敏 ADP 和血栓素受体激活肽 6 试验评估 PR。在介入治疗前和即刻评估 E-选择素和 ICAM-1。在体外,在六只猪颈动脉和五根塑料管中,在基础状态、球囊扩张后和支架植入后,测量 PR 在脉动血流中的变化。在 CA 组中,PR 下降,但在 PCI 和 RA 组中即刻显著增加,并在 24 小时时降至基线。ΔPR 在三组中均增加(P < 0.0001)。在 PCI 组中,ΔPR 与总充气时间(r = 0.435,P = 0.005)和总支架长度(r = 0.586,P < 0.001)直接相关。E-选择素的变化与ΔPR 呈显著负相关(P < 0.001)。与 sICAM-1 无相关性。与无 PMI 患者相比,有 PMI 患者的 PR 增加更显著(P = 0.013)。在体外,在存在颈动脉的情况下观察到血小板活化,但在存在塑料管的情况下未观察到血小板活化。

结论

尽管进行了双联抗血小板治疗,PCI 仍会根据手术复杂性和血管损伤程度,对血小板功能产生相应影响。

相似文献

1
Periprocedural variations of platelet reactivity during elective percutaneous coronary intervention.择期经皮冠状动脉介入治疗过程中血小板反应性的围手术期变化。
J Thromb Haemost. 2012 Dec;10(12):2452-61. doi: 10.1111/jth.12016.
2
Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.替罗非班辅助经皮冠状动脉介入治疗患者术前双联抗血小板治疗对围术期心肌梗死的影响。
Thromb Res. 2018 Apr;164:17-23. doi: 10.1016/j.thromres.2018.02.008. Epub 2018 Feb 15.
3
Association between changes in platelet reactivity during elective percutaneous coronary intervention and periprocedural myocardial infarction: A pilot study.择期经皮冠状动脉介入治疗过程中血小板反应性变化与围术期心肌梗死的关系:一项初步研究。
J Cardiol. 2019 Feb;73(2):134-141. doi: 10.1016/j.jjcc.2018.07.006. Epub 2018 Sep 7.
4
Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.稳定性冠状动脉疾病患者经皮冠状动脉介入治疗后的血小板反应性与心血管事件:比利时支架血栓形成(STIB)试验
EuroIntervention. 2014 Jun;10(2):204-11. doi: 10.4244/EIJV10I2A34.
5
Platelet reactivity and coronary microvascular impairment after percutaneous revascularization in stable patients receiving clopidogrel or prasugrel.稳定型冠心病患者经皮血运重建术后应用氯吡格雷或普拉格雷的血小板反应性与冠状动脉微血管功能障碍。
Atherosclerosis. 2018 Nov;278:23-28. doi: 10.1016/j.atherosclerosis.2018.08.044. Epub 2018 Aug 30.
6
Platelet reactivity in patients receiving a maintenance dose of P2Y12-ADP receptor antagonists undergoing elective percutaneous coronary intervention.接受维持剂量P2Y12-ADP受体拮抗剂治疗的患者在接受择期经皮冠状动脉介入治疗时的血小板反应性。
Int J Cardiol. 2016 Aug 1;216:190-3. doi: 10.1016/j.ijcard.2016.04.165. Epub 2016 May 1.
7
Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study.比伐卢定与氯吡格雷联用或不联用依替巴肽用于择期支架置入术:对血小板功能、血栓弹力图指标的影响及其与CLEAR PLATELETS-2(氯吡格雷联合依替巴肽抑制血小板反应性)研究围手术期梗死结果的关系
J Am Coll Cardiol. 2009 Feb 24;53(8):648-57. doi: 10.1016/j.jacc.2008.10.045.
8
Periprocedural myocardial damage during percutaneous coronary intervention: a point-of-care platelet testing and intravascular ultrasound/virtual histology study.经皮冠状动脉介入治疗期间的围手术期心肌损伤:即时血小板检测和血管内超声/虚拟组织学研究。
Kardiol Pol. 2013;71(4):325-33. doi: 10.5603/KP.2013.0059.
9
Relation of Platelet Indexes to Platelet Reactivity and Periprocedural Myocardial Infarction in Patients Who Underwent Percutaneous Coronary Angioplasty.经皮冠状动脉介入治疗患者血小板指标与血小板反应性及围手术期心肌梗死的关系
Am J Cardiol. 2018 May 1;121(9):1027-1031. doi: 10.1016/j.amjcard.2018.01.013. Epub 2018 Feb 5.
10
Antiplatelet and myocardial protective effect of Shexiang Tongxin Dropping Pill in patients undergoing percutaneous coronary intervention: A randomized controlled trial.麝香通心滴丸对行经皮冠状动脉介入治疗患者的抗血小板及心肌保护作用:一项随机对照试验。
J Integr Med. 2022 Mar;20(2):126-134. doi: 10.1016/j.joim.2022.01.001. Epub 2022 Jan 4.

引用本文的文献

1
The predictive value of the neutrophil/platelet ratio on in-hospital adverse events and long-term prognosis in patients with coronary artery disease after percutaneous coronary intervention and its possible internal mechanism.中性粒细胞/血小板比值对经皮冠状动脉介入治疗后冠心病患者住院不良事件及远期预后的预测价值及其可能的内在机制。
Mol Cell Biochem. 2024 Nov;479(11):3011-3019. doi: 10.1007/s11010-023-04901-1. Epub 2023 Dec 22.
2
Impact of the Xinsorb Scaffold-Related Parameters on Platelet Reactivity in Patients with Single De Novo Coronary Artery Lesions Undergoing Clopidogrel Treatment.Xinsorb 支架相关参数对氯吡格雷治疗的单支初发冠状动脉病变患者血小板反应性的影响。
Anatol J Cardiol. 2023 Jul 3;27(7):408-416. doi: 10.14744/AnatolJCardiol.2023.3071. Epub 2023 Jun 7.
3
The Procedural and Clinical Outcomes of Rotational Atherectomy in Patients Presenting With Acute Myocardial Infarction.急性心肌梗死患者旋磨术的手术及临床结果
Front Cardiovasc Med. 2022 Mar 18;9:846564. doi: 10.3389/fcvm.2022.846564. eCollection 2022.
4
Invasive Assessment of Coronary Microvascular Function.冠状动脉微血管功能的有创评估
J Clin Med. 2021 Dec 31;11(1):228. doi: 10.3390/jcm11010228.
5
Impact of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio on 5-Year Clinical Outcomes of Patients with Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值对择期经皮冠状动脉介入治疗稳定型冠状动脉疾病患者 5 年临床结局的影响。
J Cardiovasc Transl Res. 2018 Dec;11(6):517-523. doi: 10.1007/s12265-018-9829-6. Epub 2018 Oct 1.
6
Impact of platelet reactivity on 5-year clinical outcomes following percutaneous coronary intervention: a landmark analysis.血小板反应性对经皮冠状动脉介入治疗后 5 年临床结局的影响: landmark 分析。
J Thromb Thrombolysis. 2018 May;45(4):496-503. doi: 10.1007/s11239-018-1630-5.
7
Double-blind parallel placebo-controlled study to evaluate the effect of molsidomine on the endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: the MEDCOR Trial.双盲平行安慰剂对照研究评价吗地尔对经皮冠状动脉介入治疗稳定型心绞痛患者内皮功能障碍的影响:MEDCOR 试验。
J Cardiovasc Transl Res. 2014 Mar;7(2):226-31. doi: 10.1007/s12265-013-9513-9. Epub 2013 Oct 19.
8
St. John's Wort in patients non-responders to clopidogrel undergoing percutaneous coronary intervention: a single-center randomized open-label trial (St. John's Trial).圣约翰草在经皮冠状动脉介入治疗中对氯吡格雷无反应的患者中的应用:一项单中心随机开放标签试验(圣约翰试验)。
J Cardiovasc Transl Res. 2013 Jun;6(3):411-4. doi: 10.1007/s12265-013-9455-2. Epub 2013 Mar 6.
9
Influence of platelet reactivity on clinical outcome of patients with stable coronary artery disease.血小板反应性对稳定性冠心病患者临床结局的影响。
J Cardiovasc Transl Res. 2013 Jun;6(3):346-54. doi: 10.1007/s12265-012-9439-7. Epub 2013 Jan 3.
10
Clinical implications of platelet-vessel interaction.血小板-血管相互作用的临床意义。
J Cardiovasc Transl Res. 2013 Jun;6(3):310-5. doi: 10.1007/s12265-012-9441-0. Epub 2012 Dec 28.